Literature DB >> 1738421

Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody.

H Morita1, K Maeda, M Obayashi, T Shinzato, A Nakayama, Y Fujita, I Takai, H Kobayakawa, I Inoue, S Sugiyama.   

Abstract

The present experiment demonstrated that an irreversible glomerulosclerosis could be induced in the rat through repeated intravenous administrations of OX-7 (a monoclonal anti-Thy-1.1 antibody). Rats were injected with 0.2 mg of affinity-purified OX-7 at 1-week intervals for a period of 4 weeks. Glomerular damage was periodically examined at light-microscopic level. Thirty-five days after the initial injection (7 days after the final injection), capillary aneurysms and expansion of the mesangial areas with hypercellularity were frequently observed. Similar glomerular damage was also observed in rats 7 days after they received a single injection of either 1.0 or 0.2 mg of OX-7. After repeated injections, 112 days from the initial administration (84 days after the final injection), approximately 60% of the glomeruli had expanded mesangial areas with an apparent increase in the mesangial matrix. The result contrasts sharply with that obtained from a single injection of OX-7 in that more than 85% of the glomeruli showed no abnormalities 84 days after the injection. This chronic model, as a result of repeated injections of the antibody, could serve as a potential for further investigation of the mechanisms involved in the development of chronic glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738421     DOI: 10.1159/000186711

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation.

Authors:  T Hirai; T Masaki; M Kuratsune; N Yorioka; N Kohno
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture.

Authors:  N Nakao; N Hiraiwa; A Yoshiki; F Ike; M Kusakabe
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

Review 4.  An evaluation of experimental models of glomerulonephritis.

Authors:  P N Furness; K Harris
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

5.  Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis.

Authors:  Andrew Wallace McGowan Minto; Lars-Peter Erwig; Andrew Jackson Rees
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

6.  Advances in targeting drug delivery to glomerular mesangial cells by long circulating cationic liposomes for the treatment of glomerulonephritis.

Authors:  Katsumi Morimoto; Masayo Kondo; Kazuo Kawahara; Hideto Ushijima; Yasuhiko Tomino; Masaharu Miyajima; Junji Kimura
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

7.  Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis.

Authors:  Wenjia Geng; Ribao Wei; Shuwen Liu; Li Tang; Hanyu Zhu; Pu Chen; Jie Wu; Xueguang Zhang; Fei Zhu; Zhong Yin; Xiangmei Chen
Journal:  Biol Res       Date:  2016-03-11       Impact factor: 5.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.